Recruiting Melanoma Studies in Cleveland
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN2810, also known as cemiplimab (each individually call...
Neoadjuvant Darovasertib in Primary Uveal Melanoma
This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)...
About Melanoma Clinical Trials in Cleveland
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.
There are currently 2 melanoma clinical trials recruiting participants in Cleveland, OH. These studies are seeking a combined 2,055 participants. Research is being sponsored by Regeneron Pharmaceuticals, IDEAYA Biosciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Melanoma Clinical Trials in Cleveland — FAQ
Are there melanoma clinical trials in Cleveland?
Yes, there are 2 melanoma clinical trials currently recruiting in Cleveland, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cleveland?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you about next steps.
Are clinical trials in Cleveland free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cleveland studies also compensate for your time and travel.
What melanoma treatments are being tested?
The 2 active trials in Cleveland are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.
Data updated March 2, 2026 from ClinicalTrials.gov